等待开盘 07-10 09:30:00 美东时间
+0.510
+0.76%
今日重点评级关注:Canaccord Genuity:维持AtaiBeckley"买入"评级,目标价从15美元升至17美元;Truist Securities:维持NUVATION BIO"买入"评级,目标价从12美元升至13美元
07-08 15:31
Cantor Fitzgerald analyst Sarah James maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $60 to $75.
07-07 19:57
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away fro...
07-04 01:35
今日重点评级关注:摩根士丹利:维持杜邦"标配"评级,目标价从52美元升至156美元;蒙特利尔银行:维持Taysha Gene Therapies"跑赢大市"评级,目标价从10美元升至14美元
06-24 14:08
Centene ( ($CNC) ) has issued an update. Centene Corporation announced that eff...
06-23 05:59
瑞银近日发布报告指出,人工智能(AI)正逐步成为医疗健康领域的底层核心技术,但本轮技术变革的最大受益者并非医疗保险公司,医院反而有望依托AI构筑更稳固的长期竞争...
06-22 08:48
Centene (NYSE:CNC) has outperformed the market over the past 20 years by 2.95% on an annualized basis producing an average annual return of 12.35%. Currently, Centene has a market capitalization of $30.13 billion. Buying $100 In CNC: If an investor had bought $100 of CNC stock 20 years ago, it would...
06-19 05:30
Centene Corp. (NYSE:CNC) will offer buyouts to most employees as the health insurer seeks to reduce costs following a significant decline in membership across its health plans. The U.S. insurer launched a voluntary separation program that will allow eligible employees to apply for buyouts. However, ...
06-17 01:53
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33